Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 17, 2021
Bryant Ranch Prepack is voluntarily recalling in total 47 bottles of Spironolactone tablets to the consumer level.
read more
BSI, a business improvement and standards company, announced a collaborative partnership with Poseidon, an independent pharmaceutical logistics network, with the objective of bringing greater quality, and certainty to the global distribution of ...
read more
Wednesday, September 14, 2022
Following their recent expansion into formulation, method and lyo development, Berkshire Sterile Manufacturing (BSM) now offers two new services to assist their clients in their R&D efforts as they head towards clinical development and trials.
read more
Wednesday, October 11, 2017
BTS Research announced they have been recommended for Full Accreditation at their new headquarters following reviewers' first physical evaluation of the new vivarium.
read more
Wednesday, March 11, 2020
Burke Therapeutics has signed an exclusive marketing and supply agreement with Coeptis for the U.S. market.
read more
Wednesday, April 24, 2019
BurstIQ and the ITA announced the formation of a Strategic Partnership focused on promoting blockchain, healthcare best practices, and strategic domestic and international initiatives.
read more
C2 PHARMA has acquired the Digoxin API product portfolio of Polish company, Nobilus Ent, self-developed and inherited from Roche/Galenus Mannheim.
read more
Wednesday, November 10, 2021
C2 PHARMA, a pharmaceutical group established to focus on niche active pharmaceutical ingredients (APIs), has expanded their API product portfolio.
read more
Friday, February 26, 2021
C2 PHARMA (C2P) has expanded its portfolio of APIs and botanical extracts throughout 2020 and will continue pursuing the expansion into 2021.
read more
Wednesday, November 06, 2019
C2 PHARMA continues to build its active pharmaceutical ingredient (API) and botanical extracts product portfolio.
read more
Wednesday, October 19, 2022
C2 PHARMA, a pharmaceutical group focused on manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs) globally, is expanding the API product portfolio. Tropicamide API is launching with regulatory filings in both ...
read more
C2 PHARMA, a manufacturer and supplier of ophthalmic and niche active pharmaceutical ingredients (APIs), announced the approval of a C-DMF for Digoxin, an API manufactured by their Polish manufacturing partner Nobilus Ent.
read more
Tuesday, October 17, 2017
Cadent Therapeutics has earned a milestone payment for the initiation of a Phase 1 clinical study of a subtype selective NMDA receptor negative allosteric modulator for treatment-resistant depression.
read more
Cadent Therapeutics today announced the receipt of the second milestone payment from Novartis following the initiation of a Phase 2 clinical study of MIJ821.
read more
Wednesday, August 16, 2017
CAEK has entered into an exclusive agreement with Henry Schein Dental, a division of Henry Schein to sell its uniquely designed HIPAA software, LayerCompliance.
read more